Radiology Journals

Radiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Terasawa T et al. – Currently, 7 centers in the United States have facilities for particle (proton)–beam irradiation, and at least 4 are under construction, each costing between $100 and $225 million. In 243 eligible articles, charged–particle radiation therapy was used alone or in combination with other interventions for common (for example, lung, prostate, or breast) or uncommon (for example, skull–base tumors or uveal melanomas) types of cancer. Of 243 articles, 185 were single–group retrospective studies. Eight randomized and 9 nonrandomized clinical trials compared treatments with or without charged particles. This review found that published evidence about the benefits and harms of charged–particle radiation therapy was derived mostly from small, single–group, retrospective studies. Of the 17 studies that compared treatments with or without charged particles, none reported statistically significant or important differences in overall or cancer–specific survival or in total serious adverse events.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address